Scholars Central

Review articlePublished 26 May 2016

Inhaled loxapine for rapid treatment of agitation in schizophrenia and bipolar disorder: an update

Authors: Kimberly Nordstrom

Neuropsychiatry

Volume 2 · Issue 3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Agitation is a common presenting problem in emergency departments and treatments currently range from de-escalation techniques to medications, in either oral or intramuscular forms. Oral medications can be diverted and have a relatively long delay of onset. This delay is problematic for agitated patients in that the agitation may escalate prior to onset of action of the medication. This can lead to the need for intramuscular medications or even physical restraints. Regarding intramuscular medications, they tend to work more quickly but are highly invasive. A new delivery system using loxapine is currently beingreviewed by the US FDA for use in agitation in schizophrenia and bipolar disorder. Staccato® loxapine offers rapid delivery of loxapine by inhalation into deep lung tissue, allowing for rapid absorption into system circulation.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Neuropsychiatry.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalNeuropsychiatry
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Kimberly Nordstrom”